RO-7268489

N/A

Report date: 2026/05/23 20:00:57
NME

Base Information

Drug NameRO-7268489
Drug Alias NameRO-7268489RO7268489
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMultiple Sclerosis, Chronic Progressive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPolandPortugalNetherlands +[11
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis, Chronic Progressive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A